Skip header and navigation

Narrow By

73 records – page 3 of 4.

Macular degeneration

https://libcat.nshealth.ca/en/permalink/chpams35687
Nova Scotia Health Authority. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0460
Available Online
View Pamphlet
The retina is a very thin delicate tissue at the back of the eye that turns light into images. The macula is the very small central area of your retina. It gives you the central vision needed to do things like reading, watching TV, and seeing faces. There are 2 types of age-related macular degeneration (AMD): dry and wet. With dry AMD, changes happen slowly over months or years. There is no treatment for dry AMD. With wet (also called ‘exudative’) AMD, changes often happen quickly. It is possib…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Eye Care Centre
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Macular Degeneration
Subjects (LCSH)
Retinal degeneration
Specialty
Ophthalmology
Abstract
The retina is a very thin delicate tissue at the back of the eye that turns light into images. The macula is the very small central area of your retina. It gives you the central vision needed to do things like reading, watching TV, and seeing faces. There are 2 types of age-related macular degeneration (AMD): dry and wet. With dry AMD, changes happen slowly over months or years. There is no treatment for dry AMD. With wet (also called ‘exudative’) AMD, changes often happen quickly. It is possible to treat wet AMD. Topics include: causes, treatment, risks, what the injection feels like, what to expect after the injection, special precautions after an injection, and things you can do to help your condition. A list of symptoms requiring attention by your eye doctor is included. The French version of this pamphlet, 1678 "La dégénérescence maculaire", is also available.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
0460
Less detail

La dégénérescence maculaire

https://libcat.nshealth.ca/en/permalink/chpams35703
Nova Scotia Health Authority. QEII. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1678
Available Online
View Pamphlet
La rétine est une membrane fine et délicate à l’arrière de l’œil. Elle transforme la lumière en images. La macula est la partie centrale et toute petite de la rétine. Elle vous donne la vision centrale nécessaire pour faire des choses comme lire, regarder la télé et voir les visages. Il existe deux formes de dégénérescence maculaire liée à l’âge (DMLA) : la forme sèche et la forme humide. Dans le cas de la dégénérescence maculaire sèche, les changements se produisent lentement, durant des mois …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Eye Care Centre
Alternate Title
Macular degeneration
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Macular Degeneration
Subjects (LCSH)
Retinal degeneration
Specialty
Ophthalmology
Abstract
La rétine est une membrane fine et délicate à l’arrière de l’œil. Elle transforme la lumière en images. La macula est la partie centrale et toute petite de la rétine. Elle vous donne la vision centrale nécessaire pour faire des choses comme lire, regarder la télé et voir les visages. Il existe deux formes de dégénérescence maculaire liée à l’âge (DMLA) : la forme sèche et la forme humide. Dans le cas de la dégénérescence maculaire sèche, les changements se produisent lentement, durant des mois ou des années. Il n'y a aucun traitement pour la DMLA de forme sèche. Dans le cas de la forme humide (dite aussi exsudative) de la DMLA, les changements se produisent souvent de façon rapide. Il est possible de traiter cette forme de DMLA. Sujets abordés : causes, traitement, injections, risques, sensation provoquée par les injections, suites des injections, précautions particulières à prendre après les injections et choses à faire pour aider votre situation. On y trouve aussi une liste de symptômes exigeant l’attention de votre spécialiste des yeux.
This is a French translation of the English pamphlet, 0460, "Macular Degeneration". The retina is a very thin delicate tissue at the back of the eye that turns light into images. The macula is the very small central area of your retina. It gives you the central vision needed to do things like reading, watching TV, and seeing faces. There are 2 types of age-related macular degeneration (AMD): dry and wet. With dry AMD, changes happen slowly over months or years. There is no treatment for dry AMD. With wet (also called ‘exudative’) AMD, changes often happen quickly. It is possible to treat wet AMD. Topics include: causes, treatment, risks, what the injection feels like, what to expect after the injection, special precautions after an injection, and things you can do to help your condition. A list of symptoms requiring attention by your eye doctor is included.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
1678
Less detail

Medical abortion

https://libcat.nshealth.ca/en/permalink/chpams35888
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1831
Available Online
View Pamphlet
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1831
Less detail

Procedural abortion

https://libcat.nshealth.ca/en/permalink/chpams35889
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1832
Available Online
View Pamphlet
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Surgical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Notes
Previous title: Surgical abortion
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1832
Less detail

Options for birth after cesarean

https://libcat.nshealth.ca/en/permalink/chpams35904
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1847
Available Online
View Pamphlet
If you had your baby by cesarean birth (sometimes called “cesarean delivery”, “c-section”, or “CS”), you can still have a vaginal birth in your next pregnancy. This is called a Trial of Labour after Cesarean (TOLAC) or a Vaginal Birth after Cesarean (VBAC). What makes a VBAC safe and successful, and benefits and risks of VBAC are listed. The French version of this pamphlet 1891, "Choix d’accouchement après une césarienne", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group
Alternate Title
Options for birth after caesarean section
Options for birth after cesarean section
Options for birth after c-section
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Vaginal Birth after Cesarean
Subjects (LCSH)
Childbirth
Specialty
Gynecology
Abstract
If you had your baby by cesarean birth (sometimes called “cesarean delivery”, “c-section”, or “CS”), you can still have a vaginal birth in your next pregnancy. This is called a Trial of Labour after Cesarean (TOLAC) or a Vaginal Birth after Cesarean (VBAC). What makes a VBAC safe and successful, and benefits and risks of VBAC are listed. The French version of this pamphlet 1891, "Choix d’accouchement après une césarienne", is also available.
Responsibility
Prepared by: Maternal Child Provincial Policy Working Group Adapted from: PL-0902 with permission of IWK Health, Halifax NS © 2015
Pamphlet Number
1847
Less detail

Avortement par médicaments

https://libcat.nshealth.ca/en/permalink/chpams35925
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1861
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information. ; This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion i…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Medical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information.
This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included.
Notes
Previous title: Avortement médicamenteux
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1861
Less detail

Avortement par instruments

https://libcat.nshealth.ca/en/permalink/chpams35931
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1862
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements. ; This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedu…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Procedural abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements.
This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included.
Notes
Previous title: Avortement chirurgical
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1862
Less detail

Choix d’accouchement après une césarienne

https://libcat.nshealth.ca/en/permalink/chpams36446
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1891
Available Online
View Pamphlet
Si votre bébé est né par césarienne, vous pouvez quand même accoucher de votre prochain bébé par voie vaginale. On parle alors d’épreuve du travail après césarienne (EDTAC) ou d’accouchement vaginal après césarienne (AVAC). Ce dépliant présente ce qui favorise la sécurité et la réussite d’un AVAC, ainsi que les avantages et les risques d’un AVAC. ; This is a French translation of the English pamphlet 1847, “Options for Birth after Cesarean”. This pamphlet explains the options available to women…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Reproductive Care Program of Nova Scotia
Alternate Title
Options for birth after cesarean
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Vaginal Birth after Cesarean
Subjects (LCSH)
Childbirth
Abstract
Si votre bébé est né par césarienne, vous pouvez quand même accoucher de votre prochain bébé par voie vaginale. On parle alors d’épreuve du travail après césarienne (EDTAC) ou d’accouchement vaginal après césarienne (AVAC). Ce dépliant présente ce qui favorise la sécurité et la réussite d’un AVAC, ainsi que les avantages et les risques d’un AVAC.
This is a French translation of the English pamphlet 1847, “Options for Birth after Cesarean”. This pamphlet explains the options available to women who have had a baby by cesarean birth (sometimes called “cesarean delivery”, “c-section” or “CS”). Women who have had a cesarean often give birth vaginally in their next pregnancy. This may be referred to as Trial of Labour after Cesarean (TOLAC) or Vaginal Birth after Cesarean (VBAC). When you can plan for a VBAC, what makes a VBAC safe and successful, as well as the benefits and risks of VBAC, are listed.
Responsibility
Prepared by: Maternal Child Provincial Policy Working Group Adapted from: PL-0902 with permission of IWK Health, Halifax NS © 2015
Pamphlet Number
1891
Less detail

Trabéculoplastie sélective au laser (TSL) pour le glaucome

https://libcat.nshealth.ca/en/permalink/chpams36475
Nova Scotia Health Authority. QEII. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1912
Available Online
View Pamphlet
Vos yeux sont remplis d'un liquide fabriqué par le corps ciliaire. Ce liquide s'écoule à travers la pupille, devant le cristallin, puis sort par un drain appelé trabéculum. Le glaucome est une maladie dans laquelle une pression accrue dans l'œil endommage le nerf optique. Il survient généralement lorsque le trabéculum (drain) ne fonctionne pas et que le liquide ne peut pas s'écouler de l'œil. L'accumulation de liquide dans la partie avant de l'œil augmente la pression dans l'œil, ce qui endomma…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Eye Care Centre
Alternate Title
Selective laser trabeculoplasty (SLT) for glaucoma
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Glaucoma - surgery
Trabeculectomy
Subjects (LCSH)
Glaucoma--Surgery
Eye--Surgery
Abstract
Vos yeux sont remplis d'un liquide fabriqué par le corps ciliaire. Ce liquide s'écoule à travers la pupille, devant le cristallin, puis sort par un drain appelé trabéculum. Le glaucome est une maladie dans laquelle une pression accrue dans l'œil endommage le nerf optique. Il survient généralement lorsque le trabéculum (drain) ne fonctionne pas et que le liquide ne peut pas s'écouler de l'œil. L'accumulation de liquide dans la partie avant de l'œil augmente la pression dans l'œil, ce qui endommage le nerf optique. Ce dommage peut d'abord entraîner une perte de la vision latérale (sur les côtés). Si elle n'est pas traitée, elle peut entraîner une perte de la vision centrale. La trabéculoplastie sélective au laser (TSL) est utilisée pour traiter le glaucome chronique à angle ouvert en aidant à contrôler la pression à l'intérieur de votre œil. Un laser (faisceau lumineux très concentré) est dirigé sur les drains pour aider le liquide à circuler plus librement. Dans le présent dépliant, nous vous expliquons comment vous préparer au traitement, comment est effectué le traitement, les soins qui suivent le traitement au laser et les risques possibles.
This pamphlet is a French translation of "Selective Laser Trabeculoplasty (SLT) for Glaucoma" pamphlet 0333. Your eyes are filled with a fluid made by the ciliary body. This fluid flows through the pupil, in front of the lens, and then out through a drain called the trabecular meshwork. Glaucoma is a disease where increased pressure in the eye damages the optic nerve. It usually happens when the trabecular meshwork (drain) does not work and fluid cannot drain from the eye. Fluid buildup in the front part of the eye increases pressure in your eye, damaging the optic nerve. This damage may at first cause loss of side vision. If left untreated, it may cause loss of central vision. SLT is used to treat chronic open angle glaucoma by helping to control the pressure inside your eye. A laser (highly focused beam of light) is focused on the drains to help the fluid move more freely. The pamphlet describes getting ready for treatment, how the treatment is done, care after laser treatment, and possible risks.
Notes
Previous title: Laser trabeculoplasty for glaucoma
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
1912
Less detail

Iridotomie au laser

https://libcat.nshealth.ca/en/permalink/chpams36503
Nova Scotia Health Authority. QEII. Eye Care Centre. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1945
Available Online
View Pamphlet
Votre fournisseur de soins de santé a recommandé l'iridotomie au laser pour traiter votre glaucome à angle fermé ou aigu (un type précis de glaucome) ou pour éviter qu’il ne se développe. Le présent dépliant explique le glaucome et l'iridotomie au laser. Il décrit la préparation au traitement, le traitement et les soins après l’intervention. Les complications possibles sont aussi indiquées. ; This is a French translation of the English pamphlet 0402, “Laser Iridotomy”. Your health care provider…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Eye Care Centre
Alternate Title
Laser iridotomy
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Glaucoma, Angle-Closure
Lasers
Subjects (LCSH)
Angle-closure glaucoma
Lasers in surgery
Specialty
Ophthalmology
Abstract
Votre fournisseur de soins de santé a recommandé l'iridotomie au laser pour traiter votre glaucome à angle fermé ou aigu (un type précis de glaucome) ou pour éviter qu’il ne se développe. Le présent dépliant explique le glaucome et l'iridotomie au laser. Il décrit la préparation au traitement, le traitement et les soins après l’intervention. Les complications possibles sont aussi indiquées.
This is a French translation of the English pamphlet 0402, “Laser Iridotomy”. Your health care provider has recommended laser iridotomy to prevent or treat your angle closure glaucoma (a specific type of glaucoma). This pamphlet explains glaucoma and laser iridotomy. It describes getting ready for the treatment, how the treatment is done, and care after. Possible risks are listed.
Responsibility
Prepared by: Eye Care Centre
Pamphlet Number
1945
Less detail
Nova Scotia Health Authority. CVAD Practice Committee. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1571
Available Online
View Pamphlet
A PICC (Peripherally Inserted Central Catheter) line is a long intravenous (IV) catheter (tube). This IV is placed into a large vein in your arm and threaded into a large vein just above your heart. You may need a PICC line for long-term IV therapy of fluids and medication(s). This pamphlet explains the benefits of having a PICC line, where to go to get a PICC line, how your PICC line will be put in, what will happen after the procedure, the risks of inserting and having a PICC line, and care o…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. CVAD Practice Committee
Alternate Title
Peripherally inserted central catheter line
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Catheterization, Peripheral
Medications
Subjects (LCSH)
Catheterization
Drugs
Specialty
Medications
Abstract
A PICC (Peripherally Inserted Central Catheter) line is a long intravenous (IV) catheter (tube). This IV is placed into a large vein in your arm and threaded into a large vein just above your heart. You may need a PICC line for long-term IV therapy of fluids and medication(s). This pamphlet explains the benefits of having a PICC line, where to go to get a PICC line, how your PICC line will be put in, what will happen after the procedure, the risks of inserting and having a PICC line, and care of your PICC line. Symptoms that require you to contact your primary health care provider or call 911 are listed. What to do if the PICC line breaks or is damaged is also included.
Responsibility
Prepared by: CVAD Practice Committee
Pamphlet Number
1571
Less detail

Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2217
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully consider the risks and benefits of ESAs. The risks and benefits of ESAs are listed. Your health care team will talk with you about the risks and benefits of ESAs and other factors to consider when making the decision to take ESAs.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail

Tissue transplant in oral surgery

https://libcat.nshealth.ca/en/permalink/chpams37478
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2227
Available Online
View Pamphlet
You may need a tissue transplant during your oral (mouth) surgery. Human tissues used for transplant are called allografts. This pamphlet explains where tissues for transplant come from, what types of tissue can be transplanted, what donor tissues are screened for, the risks of tissue transplant, informed consent, and what to expect after tissue transplant surgery. What to do if you think you are having a problem related to your surgery is included. Resources for more information about tissue d…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Tissue Transplantation
Surgery, Oral
Subjects (LCSH)
Transplantation of organs, tissues, etc
Mouth--Surgery
Specialty
Oral Surgery
Abstract
You may need a tissue transplant during your oral (mouth) surgery. Human tissues used for transplant are called allografts. This pamphlet explains where tissues for transplant come from, what types of tissue can be transplanted, what donor tissues are screened for, the risks of tissue transplant, informed consent, and what to expect after tissue transplant surgery. What to do if you think you are having a problem related to your surgery is included. Resources for more information about tissue donation in Nova Scotia are provided. The French version of this pamphlet 2328, "Greffe de tissus pour chirurgie buccale," is also available.
Responsibility
Prepared by: Nova Scotia Provincial Blood Coordinating Team
Pamphlet Number
2227
Less detail

COVID-19 vaccine and cancer : third doses

https://libcat.nshealth.ca/en/permalink/chpams37496
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4009
Available Online
View Pamphlet
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms
Subjects (LCSH)
COVID-19 (Disease)
Vaccines
Cancer
Specialty
Cancer Care
Abstract
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Patient Education Committee
Pamphlet Number
4009
Less detail

Greffe de tissus pour chirurgie buccale

https://libcat.nshealth.ca/en/permalink/chpams38166
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2328
Available Online
View Pamphlet
Pendant votre chirurgie buccale (bouche), il se peut que l’on doive vous faire une greffe de tissu. Ce type de transplantation est appelé allogreffe. Cette brochure explique ce qui suit : origine des tissus greffés, types de tissus pouvant être greffés, critères de sélection des donneurs de tissus, risques liés aux greffes de tissus, consentement éclairé, à quoi s’attendre après une greffe de tissu, choses à faire si vous pensez avoir un problème lié à l’opération, ressources complémentaires su…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team
Alternate Title
Tissue Transplant in Oral Surgery
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Tissue Transplantation
Surgery, Oral
Subjects (LCSH)
Transplantation of organs, tissues, etc
Mouth--Surgery
Specialty
Oral Surgery
Abstract
Pendant votre chirurgie buccale (bouche), il se peut que l’on doive vous faire une greffe de tissu. Ce type de transplantation est appelé allogreffe. Cette brochure explique ce qui suit : origine des tissus greffés, types de tissus pouvant être greffés, critères de sélection des donneurs de tissus, risques liés aux greffes de tissus, consentement éclairé, à quoi s’attendre après une greffe de tissu, choses à faire si vous pensez avoir un problème lié à l’opération, ressources complémentaires sur le don de tissus en Nouvelle-Écosse.
This pamphlet is a French translation of the English pamphlet 2227, "Tissue Transplant in Oral Surgery". You may need a tissue transplant during your oral (mouth) surgery. Human tissues used for transplant are called allografts. This pamphlet explains where tissues for transplant come from, what types of tissue can be transplanted, what donor tissues are screened for, the risks of tissue transplant, informed consent, and what to expect after tissue transplant surgery. What to do if you think you are having a problem related to your surgery is included. Resources for more information about tissue donation in Nova Scotia are provided.
Responsibility
Prepared by: Nova Scotia Provincial Blood Coordinating Team
Pamphlet Number
2328
Less detail

Transplantation de tissus

https://libcat.nshealth.ca/en/permalink/chpams36753
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2135
Available Online
View Pamphlet
Ce dépliant fournit de l'information sur les transplantations de tissus. On y trouve une liste des tissus humains utilisés pour les transplantations. Vous y trouverez également de l'information sur la provenance des tissus à transplanter, sur les critères de sélection des tissus du donneur, sur ce à quoi vous attendre avant et après une transplantation de tissus et sur ce que vous devez faire en cas de problème lié à votre transplantation. ; This is a French translation of the English pamphlet …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Team
Alternate Title
Tissue transplant
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Tissue Transplantation
Subjects (LCSH)
Transplantation of organs, tissues, etc
Specialty
Hospitals
Abstract
Ce dépliant fournit de l'information sur les transplantations de tissus. On y trouve une liste des tissus humains utilisés pour les transplantations. Vous y trouverez également de l'information sur la provenance des tissus à transplanter, sur les critères de sélection des tissus du donneur, sur ce à quoi vous attendre avant et après une transplantation de tissus et sur ce que vous devez faire en cas de problème lié à votre transplantation.
This is a French translation of the English pamphlet 1733, “Tissue Transplant”. This pamphlet provides information about tissue transplants. A list of human tissues that are used for transplants is provided. Also included is information on where tissues for transplant come from, what donor tissues are screened for, the risks of tissue transplant, what to expect after tissue transplant surgery, and what to do if you have a problem related to your surgery. Information on whether you can find out more about your tissue donor and whether you can thank your donor family is included. Contact information for New Brunswick, Nova Scotia, and PEI is provided.
Responsibility
Prepared by: Nova Scotia Provincial Blood Coordinating Team in collaboration with the New Brunswick Organ and Tissue Program and Organ and Tissue Donation Prince Edward Island
Pamphlet Number
2135
Less detail

LEEP : loop electrosurgical excision procedure

https://libcat.nshealth.ca/en/permalink/chpams35329
Nova Scotia Health Authority. QEII. Colposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1383
Available Online
View Pamphlet
LEEP is used to treat abnormal cells on your cervix (lower part of the uterus). A special wire called a “loop” is used to send a small electrical current to the area and remove the abnormal cells. This pamphlet explains how LEEP is done, how long the treatment lasts, how to prepare for the procedure, what to expect after, if you need followup care, what risks may be involved, and when you should call the Clinic. Contact information is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Colposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Uterine Cervical Dysplasia
Precancerous Conditions--prevention and control
Subjects (LCSH)
Cervix uteri--Cancer--Prevention
Abstract
LEEP is used to treat abnormal cells on your cervix (lower part of the uterus). A special wire called a “loop” is used to send a small electrical current to the area and remove the abnormal cells. This pamphlet explains how LEEP is done, how long the treatment lasts, how to prepare for the procedure, what to expect after, if you need followup care, what risks may be involved, and when you should call the Clinic. Contact information is provided.
Responsibility
Prepared by: Colposcopy Clinic
Pamphlet Number
1383
Less detail
Nova Scotia Health Authority. Emergency Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1543
Available Online
View Pamphlet
Gallstones start as small pieces and can get bigger over time. They can cause problems if they block the tubes that bile needs to travel through. This pamphlet explains what causes gallstones, symptoms of gallstones, what to do if you have a gallbladder attack, and how gallstones are diagnosed and treated. Diet tips, information about surgery and ERCP (Endoscopic Retrograde Cholangiopancreatography), and the possible risks of gallstones are also provided. A list of symptoms that require immedia…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Emergency Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Gallstones - prevention & control
Subjects (LCSH)
Gallstones
Abstract
Gallstones start as small pieces and can get bigger over time. They can cause problems if they block the tubes that bile needs to travel through. This pamphlet explains what causes gallstones, symptoms of gallstones, what to do if you have a gallbladder attack, and how gallstones are diagnosed and treated. Diet tips, information about surgery and ERCP (Endoscopic Retrograde Cholangiopancreatography), and the possible risks of gallstones are also provided. A list of symptoms that require immediate medical attention are listed. The French version of this pamphlet 2087, "Calculs biliaires", is also available.
Responsibility
Prepared by: Emergency Services
Pamphlet Number
1543
Less detail

La transfusion sanguine

https://libcat.nshealth.ca/en/permalink/chpams35870
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program, IWK Health. Nova Scotia Provincial Blood Coordinating Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1811
Available Online
View Pamphlet
Vous ou un membre de votre famille pourriez avoir besoin d’une transfusion sanguine. L’équipe de soins de santé vous expliquera en quoi consiste une transfusion ainsi que les avantages et les risques que cela comporte. Le dépliant explique en quoi consiste une transfusion sanguine, pourquoi vous ou un membre de votre famille pourriez avoir besoin d’une transfusion, ce que sont les composants et les produits sanguins, la provenance du sang, d’autres options possibles et ce qui se passe au moment…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Provincial Blood Coordinating Program
IWK Health. Nova Scotia Provincial Blood Coordinating Program
Alternate Title
Blood transfusion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Blood Transfusion
Subjects (LCSH)
Blood--Transfusion
Specialty
Hematology
Abstract
Vous ou un membre de votre famille pourriez avoir besoin d’une transfusion sanguine. L’équipe de soins de santé vous expliquera en quoi consiste une transfusion ainsi que les avantages et les risques que cela comporte. Le dépliant explique en quoi consiste une transfusion sanguine, pourquoi vous ou un membre de votre famille pourriez avoir besoin d’une transfusion, ce que sont les composants et les produits sanguins, la provenance du sang, d’autres options possibles et ce qui se passe au moment de la transfusion. Les symptômes qui exigent immédiatement des soins médicaux sont indiqués.
This pamphlet is a French translation of "Blood Transfusion" pamphlet 1200. You or your family member may need a blood transfusion. The health care team will describe the benefits and risks of a transfusion and what is involved. This pamphlet explains what a blood transfusion is, why you or your family member may need a transfusion, what blood components and products are, where the blood comes from, other options, and what will happen when the transfusion takes place. Symptoms needing immediate medical attention are listed.
Responsibility
Prepared by: Nova Scotia Provincial Blood Coordinating Program
Pamphlet Number
1811
Less detail

Heparin bladder instillation

https://libcat.nshealth.ca/en/permalink/chpams36491
Nova Scotia Health Authority. QEII. Urology Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1935
Available Online
View Pamphlet
Heparin bladder instillation is a treatment to help with interstitial cystitis (also known as painful bladder syndrome). This pamphlet explains how this treatment is done, how to get ready for your appointment, what happens during your appointment, and possible risks. Tips to ease discomfort are provided. How to spot if you have an infection and what to do are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Urology Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Administration, Intravesical
Cystitis, Interstitial - drug therapy
Subjects (LCSH)
Interstitial cystitis
Bladder--Diseases
Abstract
Heparin bladder instillation is a treatment to help with interstitial cystitis (also known as painful bladder syndrome). This pamphlet explains how this treatment is done, how to get ready for your appointment, what happens during your appointment, and possible risks. Tips to ease discomfort are provided. How to spot if you have an infection and what to do are listed.
Responsibility
Prepared by: Urology Clinic, QEII
Pamphlet Number
1935
Less detail

73 records – page 3 of 4.